[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR17C0008I1 - Derives de (thio) carbamoyl-cyclohexane utilises en tant qu'antagonistes des recepteurs d3/d2 - Google Patents

Derives de (thio) carbamoyl-cyclohexane utilises en tant qu'antagonistes des recepteurs d3/d2

Info

Publication number
FR17C0008I1
FR17C0008I1 FR17C0008C FR17C0008C FR17C0008I1 FR 17C0008 I1 FR17C0008 I1 FR 17C0008I1 FR 17C0008 C FR17C0008 C FR 17C0008C FR 17C0008 C FR17C0008 C FR 17C0008C FR 17C0008 I1 FR17C0008 I1 FR 17C0008I1
Authority
FR
France
Prior art keywords
carbamoyl
thio
receptor antagonists
derivatives used
cyclohexane derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR17C0008C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Nyrt
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of FR17C0008I1 publication Critical patent/FR17C0008I1/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
FR17C0008C 2003-08-04 2017-10-10 Derives de (thio) carbamoyl-cyclohexane utilises en tant qu'antagonistes des recepteurs d3/d2 Active FR17C0008I1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0302451A HU227534B1 (en) 2003-08-04 2003-08-04 (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
PCT/HU2004/000056 WO2005012266A1 (fr) 2003-08-04 2004-05-21 Derives de (thio) carbamoyl-cyclohexane utilises en tant qu'antagonistes des recepteurs d3/d2

Publications (1)

Publication Number Publication Date
FR17C0008I1 true FR17C0008I1 (fr) 2018-12-07

Family

ID=89981557

Family Applications (1)

Application Number Title Priority Date Filing Date
FR17C0008C Active FR17C0008I1 (fr) 2003-08-04 2017-10-10 Derives de (thio) carbamoyl-cyclohexane utilises en tant qu'antagonistes des recepteurs d3/d2

Country Status (37)

Country Link
US (2) US7737142B2 (fr)
EP (1) EP1663996B1 (fr)
JP (1) JP3999806B2 (fr)
KR (1) KR100870284B1 (fr)
CN (1) CN1829703B (fr)
AU (1) AU2004261490B2 (fr)
BE (1) BE2017C045I2 (fr)
BR (1) BRPI0413283B8 (fr)
CA (1) CA2532818C (fr)
CY (2) CY1113099T1 (fr)
DK (1) DK1663996T3 (fr)
EA (1) EA009022B1 (fr)
ES (1) ES2389840T3 (fr)
FR (1) FR17C0008I1 (fr)
HK (1) HK1093494A1 (fr)
HR (1) HRP20120715T1 (fr)
HU (2) HU227534B1 (fr)
IL (1) IL172746A (fr)
IS (1) IS2905B (fr)
LT (1) LTC1663996I2 (fr)
LU (1) LUC00039I2 (fr)
MA (1) MA28024A1 (fr)
ME (1) ME00564A (fr)
MX (1) MXPA06001033A (fr)
MY (1) MY142760A (fr)
NL (1) NL300913I2 (fr)
NO (2) NO334973B1 (fr)
NZ (1) NZ544999A (fr)
PL (1) PL1663996T3 (fr)
PT (1) PT1663996E (fr)
RS (1) RS52771B (fr)
SI (1) SI1663996T1 (fr)
TN (1) TNSN05328A1 (fr)
TW (1) TWI327141B (fr)
UA (1) UA84022C2 (fr)
WO (1) WO2005012266A1 (fr)
ZA (1) ZA200601026B (fr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007106746A (ja) * 2005-09-13 2007-04-26 Tosoh Corp 新規アリールホモピペラジン類、またはその塩と製造方法
EP1870405A1 (fr) * 2006-06-22 2007-12-26 Bioprojet (Aza)cyclohexanes carbonylées comme ligands du récepteur D3 de la dopamine
CA2667511A1 (fr) * 2006-10-31 2008-05-08 F. Hoffmann-La Roche Ag Derives d'ether modulateurs doubles des recepteurs 5-ht2a et d3
HUP0700269A2 (en) 2007-04-11 2009-04-28 Richter Gedeon Nyrt Pyrimidinyl-piperazines useful as d3/d2 receptor ligands, pharmaceutical compositions containing them and their use
HU230748B1 (hu) * 2007-05-11 2018-02-28 Richter Gedeon Nyrt Új piperazin só és előállítási eljárása
AU2008251520B2 (en) * 2007-05-11 2014-03-06 Richter Gedeon Nyrt. Novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
HUP0700369A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia
LT2185155T (lt) * 2007-08-03 2017-12-11 Richter Gedeon Nyrt. Farmacinės kompozicijos, turinčios dopamino receptoriaus ligandus, ir gydymo būdai, naudojant dopamino receptoriaus ligandus
US7875610B2 (en) 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
WO2009104739A1 (fr) 2008-02-21 2009-08-27 田辺三菱製薬株式会社 Préparation solide pour administration orale
US20090275597A1 (en) * 2008-05-02 2009-11-05 Forest Laboratories Holdings Limited Methods of treating cns disorders
JP5774988B2 (ja) * 2008-07-16 2015-09-09 リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ ドーパミン受容体リガンドからなる製剤処方
HU230067B1 (hu) * 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800766A2 (en) * 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
HUP0800765A2 (en) * 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
WO2010126527A1 (fr) * 2009-05-01 2010-11-04 Forest Laboratories Holdings Limited Méthodes de traitement des affections du snc
WO2011060363A2 (fr) * 2009-11-16 2011-05-19 Auspex Pharmaceuticals, Inc. Modulateurs des récepteurs d2 et/ou des récepteurs d3 à base de cyclohexylurée
HUP0900790A2 (en) 2009-12-17 2011-09-28 Richter Gedeon Nyrt A new process for the preparation of piperazine and their hydrochloric salts
CN103130737B (zh) * 2011-12-05 2015-12-02 江苏恒谊药业有限公司 环己烷胺类化合物及其作为抗精神分裂症药物的应用
US8912197B2 (en) 2012-08-20 2014-12-16 Forest Laboratories Holdings Ltd. Crystalline form of carbamoyl-cyclohexane derivatives
JP6448541B2 (ja) * 2012-10-11 2019-01-09 サザン リサーチ インスティテュート アミノアルキルピペラジンの尿素及びアミド誘導体並びにその使用
HU231227B1 (hu) 2012-11-29 2022-03-28 Richter Gedeon Nyrt. Transz-4-{2-[4-(2,3-diklórfenil)-piperazin-1-il]-etil}N,N-dimetilkarbamoil-ciklohexilamin skizofrénia negatív tüneteinek kezelésére
ITMI20131693A1 (it) * 2013-10-14 2015-04-15 Chemo Res S L Derivati della 1,4-cicloesilammina e loro preparazione
CN105085346B (zh) * 2015-08-14 2017-03-29 天津小新医药科技有限公司 含胺基的l-薄荷醇类p2y12受体拮抗剂及其用途
CN105085345B (zh) * 2015-08-14 2016-09-14 天津小新医药科技有限公司 含硝基的l-薄荷醇类p2y12受体拮抗剂及其用途
CN105218484B (zh) * 2015-09-14 2018-02-23 安徽省逸欣铭医药科技有限公司 酒石酸卡利拉嗪及其制备方法和医药用途
CN106518841B (zh) * 2015-09-15 2019-03-05 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
CN106543039A (zh) * 2015-09-22 2017-03-29 江苏恩华药业股份有限公司 一种用于制备卡利拉嗪的化合物及其制备方法
CN106560179B (zh) * 2015-09-30 2020-02-21 石药集团中奇制药技术（石家庄）有限公司 盐酸卡利拉嗪药物组合物及其制备方法
CN105330616B (zh) * 2015-12-09 2017-09-26 苏州明锐医药科技有限公司 卡利拉嗪的制备方法
EP3231418A1 (fr) 2016-04-14 2017-10-18 Richter Gedeon Nyrt. Formulation granulée pour administration orale
HU231173B1 (hu) 2016-07-08 2021-06-28 Richter Gedeon Nyrt. Ipari eljárás cariprazine előállítására
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
EP3495363B1 (fr) 2016-07-28 2023-08-23 Shionogi & Co., Ltd Composés cycliques condensés contenant de l'azote ayant un effet antagoniste du récepteur de la dopamine d3
CN107793350B (zh) * 2016-09-05 2021-06-04 上海医药工业研究院 芳乙基哌啶基衍生物及其治疗精神分裂症的应用
HUP1700253A1 (hu) 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények
WO2018229794A1 (fr) 2017-06-13 2018-12-20 Cipla Limited Forme amorphe de cariprazine
JP7250405B2 (ja) 2018-01-26 2023-04-03 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する環式化合物
MX2020007849A (es) 2018-01-26 2020-09-25 Shionogi & Co Compuesto ciclico condensado que tiene efecto antagonista del receptor de dopamina d3.
CN108586389B (zh) * 2018-06-29 2020-06-12 成都福柯斯医药技术有限公司 一种合成卡利拉嗪的方法
CN110872262A (zh) 2018-08-29 2020-03-10 上海科胜药物研发有限公司 一种卡利拉嗪的合成方法
CN110872269B (zh) * 2018-08-30 2024-06-07 浙江京新药业股份有限公司 一种环己烷衍生物的盐
CN110872270A (zh) * 2018-08-30 2020-03-10 浙江京新药业股份有限公司 一种环己烷衍生物的盐
CN111320594A (zh) * 2018-12-13 2020-06-23 江苏恩华药业股份有限公司 一种卡利拉嗪杂质及其制备工艺和用途
HU231500B1 (hu) 2019-04-10 2024-04-28 Richter Gedeon Nyrt Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
CN112239433B (zh) * 2019-07-17 2024-05-14 北京盈科瑞创新药物研究有限公司 一种环己烷衍生物、制备方法及其应用
CN110372557B (zh) * 2019-08-06 2021-05-18 上海勋和医药科技有限公司 环己烷胺类d3/d2受体部分激动剂
BR112022007238A2 (pt) 2019-10-29 2022-07-05 Shanghai Hansoh Biomedical Co Ltd Compostos modificadores derivados de anel de quatro membros, métodos para preparar os referidos compostos, composição e uso
CN112778183B (zh) 2019-11-05 2024-05-10 江苏豪森药业集团有限公司 含氮环类衍生物调节剂、其制备方法和应用
HUP2100108A1 (hu) 2021-03-12 2022-09-28 Richter Gedeon Nyrt Eljárás és berendezés gyógyászatilag alkalmazható piperazin származékok folyamatos áramú, áramlásos konszekutív redukálással történõ elõállítására
CN117242058A (zh) 2021-04-28 2023-12-15 上海翰森生物医药科技有限公司 含哌嗪多环类衍生物的盐及晶型及其制备方法和应用
HUP2100259A1 (hu) 2021-07-07 2023-01-28 Richter Gedeon Nyrt Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények
JP2024534364A (ja) 2021-09-15 2024-09-20 リヒター ゲデオン ニュイルヴァーノシャン ミューコェデー レースヴェーニュタールシャシャーグ （１ｒ，４ｒ）－４－置換シクロヘキサン－１－アミンを生成する方法
HUP2200312A1 (hu) 2022-08-05 2024-02-28 Richter Gedeon Nyrt Kariprazin tartalmú szájban diszpergálódó tabletta
WO2024072930A1 (fr) * 2022-09-30 2024-04-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Agonistes partiels du récepteur d3/d2 de la dopamine destinés au traitement de troubles neuropsychiatriques
KR20240112213A (ko) 2023-01-11 2024-07-18 리히터 게데온 닐트. 도파민 d3/d2 수용체 조절 화합물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977110A (en) 1995-09-22 1999-11-02 Warner-Lambert Company Substituted cyclohexylamines as central nervous systems agents
MXPA00009569A (es) 1998-03-31 2002-08-06 Acadia Pharm Inc Compuestos con actividad en receptores muscarinicos.
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
SE9802208D0 (sv) 1998-06-22 1998-06-22 Astra Pharma Inc Novel compounds
HU227543B1 (en) * 2001-09-28 2011-08-29 Richter Gedeon Nyrt N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HUP0302451A2 (hu) 2005-05-30
TWI327141B (en) 2010-07-11
UA84022C2 (ru) 2008-09-10
EA009022B1 (ru) 2007-10-26
HUS1700044I1 (hu) 2017-11-28
CY2017032I2 (el) 2018-02-14
US20100240640A1 (en) 2010-09-23
HRP20120715T1 (hr) 2012-09-30
JP2007501215A (ja) 2007-01-25
US20060229297A1 (en) 2006-10-12
LTPA2017027I1 (lt) 2017-09-25
KR100870284B1 (ko) 2008-11-25
HU0302451D0 (en) 2003-10-28
ES2389840T3 (es) 2012-11-02
DK1663996T3 (da) 2012-10-01
CY2017032I1 (el) 2018-02-14
IS2905B (is) 2014-10-15
NZ544999A (en) 2009-07-31
CN1829703B (zh) 2011-06-08
CY1113099T1 (el) 2016-04-13
NO334973B1 (no) 2014-08-11
ZA200601026B (en) 2007-05-30
NL300913I2 (nl) 2017-12-20
BE2017C045I2 (fr) 2023-08-09
ME00564B (me) 2011-12-20
CA2532818A1 (fr) 2005-02-10
LUC00039I2 (fr) 2017-12-20
NL300913I1 (fr) 2017-11-23
EP1663996A1 (fr) 2006-06-07
SI1663996T1 (sl) 2012-10-30
IL172746A0 (en) 2006-04-10
AU2004261490B2 (en) 2008-08-21
RS20060041A (en) 2009-11-10
CA2532818C (fr) 2009-07-14
KR20060058096A (ko) 2006-05-29
IL172746A (en) 2016-02-29
HU227534B1 (en) 2011-08-29
LUC00039I1 (fr) 2017-10-16
HK1093494A1 (en) 2007-03-02
CN1829703A (zh) 2006-09-06
TNSN05328A1 (en) 2007-07-10
AU2004261490A1 (en) 2005-02-10
TW200505874A (en) 2005-02-16
WO2005012266A1 (fr) 2005-02-10
NO2017051I1 (no) 2017-10-09
MY142760A (en) 2010-12-31
LTC1663996I2 (lt) 2018-05-25
NO2017051I2 (no) 2018-11-19
US7737142B2 (en) 2010-06-15
RS52771B (en) 2013-10-31
IS8199A (is) 2005-12-22
EA200600364A1 (ru) 2006-06-30
BRPI0413283A (pt) 2006-10-10
JP3999806B2 (ja) 2007-10-31
EP1663996B1 (fr) 2012-06-20
MXPA06001033A (es) 2006-04-24
BRPI0413283B1 (pt) 2021-10-05
PT1663996E (pt) 2012-09-24
ME00564A (en) 2011-12-20
NO20061076L (no) 2006-03-06
BRPI0413283B8 (pt) 2021-10-05
MA28024A1 (fr) 2006-07-03
PL1663996T3 (pl) 2012-11-30

Similar Documents

Publication Publication Date Title
FR17C0008I1 (fr) Derives de (thio) carbamoyl-cyclohexane utilises en tant qu'antagonistes des recepteurs d3/d2
FR20C1039I2 (fr) Derives de l'uk-2a
MA27680A1 (fr) Derives de 4-phenyl-pyridine en tant qu'antagonistes du recepteur de la neurokinine-1
FR18C1024I1 (fr) Derives d'heterocyclocarboxamide
MA26958A1 (fr) Derives de 2-phenylaminoimidazoline phenyl cetone substituee en tant qu'antagonistes ip
NO20041504L (no) Lactamderivater som antagonister for humane 11CBY reseptorer.
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
FR15C0086I2 (fr) Derives d'hydroxamate en tant qu'inhibiteurs de desacetylase
MA27679A1 (fr) Derives d'acides carboxyliques en tant qu'antagonistes ip
MA26971A1 (fr) Derives de phenylethenyle ou de phenylethinyle en tant qu'antagonistes de recepteur de glutamate
MA28393B1 (fr) Dérivés de triazole servant d'antagonistes de la vasopressine
MA28479B1 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
DZ3443A1 (fr) Derives de 3-aroylindole et leur utilisation en tant qu'agonistes des recepteurs cb2
MA26933A1 (fr) Derives de 4-phenyl-pyridine en tant qu'antagonistes de recepteur de la neurokinine 1.
DK1440059T3 (da) 3-azabicyclo(3.1.0)hexanderivater som opioidreceptorantagonister
FR2813756B1 (fr) Dilueur pour la conservation de spermatozoides de porcins
MA27046A1 (fr) Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens.
MA28177A1 (fr) 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate ou tosylate en tant qu'agents antipsychotiques
ATE309994T1 (de) Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten
MA27094A1 (fr) Derives triazolo-quinoline utiles en tant que ligands recepteurs d'adenosine.
DE60214408D1 (de) 5-METHOXY-8-ARYL-i1,2,4öTRIAZOLOi1,5-AöPYRIDINE DERIVATIVE ALS ADENOSIN-REZEPTOR ANTAGONISTEN
DE50206910D1 (de) Substituierte y-lactonverbindungen als nmda-antagonisten
FR2838339B1 (fr) Derives poly-phosphonates pour compositions dentifrices
ATE348799T1 (de) Substituierte cyclohexanderivate
ES1053013Y (es) Enganche para la articulacion de respaldos oscilantes